Furthermore, in February 2019, Danaher acquired Biopharma business of GE Life Sciences for US$ 21.4 billion, thus adding biopharmaceutical research, development, and manufacturing instruments, equipment, and consumables to Danaher’s Life Science group.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients